WO2017195951A1 - Cosmetic and nutritional supplement using aptamer, and method for producing same - Google Patents
Cosmetic and nutritional supplement using aptamer, and method for producing same Download PDFInfo
- Publication number
- WO2017195951A1 WO2017195951A1 PCT/KR2016/011741 KR2016011741W WO2017195951A1 WO 2017195951 A1 WO2017195951 A1 WO 2017195951A1 KR 2016011741 W KR2016011741 W KR 2016011741W WO 2017195951 A1 WO2017195951 A1 WO 2017195951A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- aptamer
- antioxidant
- extract
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
Definitions
- the present invention relates to cosmetics and nutritional supplements using aptamers and to a method of manufacturing the same, and more particularly, to cosmetics and nutritional supplements using long-term maintenance and antioxidant properties of antioxidants such as reduced vitamin C by aptamers. Is to apply.
- ROS active oxygen species
- Antioxidants can be divided into those that exist naturally in the human body and those that are administered externally.
- Antioxidants that are naturally present in the human body include enzymes such as superoxide dismutase (SOD), glutathione, peroxidase and catalase. phytochemicals such as kaempferol, catechin and genistein; Vitamin E, vitamin C and beta carotene; And minerals such as selenium.
- SOD superoxide dismutase
- glutathione glutathione
- peroxidase and catalase
- phytochemicals such as kaempferol, catechin and genistein
- Vitamin E Vitamin C and beta carotene
- minerals such as selenium.
- Vitamin C L-ascorbic acid, ascorbate
- Vitamin C deficiency will cause diseases such as scurvy (Scurvy).
- Vitamin C in animals is an important factor in preventing wound healing and capillary bleeding, and is an important antioxidant in the body along with Vitamin A and Vitamin E.
- UVA UVA
- UVB ultraviolet B
- pollutants pollutants
- stress smoking, drinking, fatty foods, etc.
- cells may age or die.
- these substances reduce or degenerate the production of collagen and elastin, causing the skin to lose elasticity and wrinkles.
- antioxidants such as vitamin A, C, E
- the present invention has been made in view of the above necessity, and an object of the present invention is to provide a substance which acts as an antioxidant for antioxidant substances.
- the present invention provides an aptamer for preventing oxidation of an antioxidant substance.
- the present invention also provides an aptamer and an antioxidant complex obtained by combining an antioxidant with the aptamer of the present invention.
- the antioxidant is preferably a substance selected from the group consisting of vitamin C, vitamin A, retinol, vitamin E, astaxanthin, resveratinol, polyphenols, coenzyme Q10, peptides and oils.
- the antioxidant is not limited thereto.
- the present invention provides a cosmetic composition comprising the aptamer and antioxidant complex of the present invention as an active ingredient.
- the cosmetic composition preferably further comprises one or more of collagen, elastin, hyaluronic acid, and a peptide, but is not limited thereto.
- the cosmetic composition is to release the bound antioxidant (eg, vitamin C) when the structure of the aptamer changes according to the ultraviolet irradiation of the skin, or ATP according to the change in the temperature or acidity of the skin It is preferable to release vitamin C as the structure of the aptamer which binds thereto when the amount is changed, but is not limited thereto.
- the bound antioxidant eg, vitamin C
- the cosmetic composition of the present invention can use any raw material used in cosmetics regardless of any kind of extracts, active substances.
- green tea extract, licorice extract, medicinal extract, lettuce extract, golden extract, pueraria extract, red ginseng extract and apricot extract oil extract, orange extract, lemon extract, bamboo extract guava extract Rosemary Extract Cornus Extract, Ganoderma Lucidum Extract Ginkgo Extract Seoxiok-Yuksan Extract Consonant Extract, Moisturizing Chinese Quince Extract, White Lotus Extract, Paprika Extract, Aloe Extract, Scrubber Extract, Seaweed Extract, Antioxidant Carrot Extract, Soybean Extract, Grapefruit Extract Grape Seed Extract, Portulaca Extract, Caviar to Improve Wrinkles, Pomegranate, Ginseng Extract, Peach Extract for Skin Regeneration, Cheongung Extract, Centella asiatic Extract, Chamomile Extract, Licorice Extract, Ginseng Extract, Angelica Extract, Acne Good peppermint extract, triticale extract, eosungcho extract , Pe
- the present invention provides a nutritional supplement composition comprising the aptamer and antioxidant complex of the present invention as an active ingredient.
- vitamins for the nutritional supplements of the present invention include vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B 6, vitamin B 12, thiamine, riboflavin, biotin, folic acid, niacin, pantothenic acid, mixtures thereof, and the like. to be.
- suitable mineral nutrients to be included in the dietary supplement composition are selected from sodium, potassium, calcium, magnesium, phosphorus, sulfur, chlorine, iron, copper, iodine, zinc, selenium, manganese, chromium, molybdenum, fluorine, cobalt, and compounds thereof They hold more than one element.
- herbs can also be used as nutritional supplements.
- herbs are selected from those having various medicinal or dietary supplement properties.
- herbs are aromatic plants or parts of plants that can be used for medicinal or flavoring purposes.
- the present invention provides a method for binding an aptamer to an antioxidant to maintain the reduced state of the antioxidant and prevent oxidation.
- the present invention like Vitamin C, vitamin A (Retinol), Vitamin E, Astaxanthin, Resveratinol, Polyphenol, Coenzyme Q10, Peptide, Oil, etc. Can be used to manufacture. This prevents the oxidation (corrosion) of the materials to ensure that they maintain the maximum effect they require. In addition, by releasing it under a target condition through apta-sensing, the effect can be increased as much as possible.
- Aptamer is a method of detecting a specific substance by using the three-dimensional structure of single strand DNA or RNA, which is similar to an antigen-antibody reaction, but has a much smaller substance, and can be controlled in various ways. This is an easy advantage. In addition, unlike antibodies, it is possible to synthesize aptamers that bind to very small chemicals (vitamins) and the like.
- Vitamin C is a water-soluble six carbon compound, which includes the 3-, 4- and 3-hydrocarbons of the furan ring and the semidehydroascorbic acid and dehydroascorbic acid, which are oxidized in the reduced form and biparticulate, respectively.
- Vitamin C which is combined with aptamers and maintains a reduced state, may be used in skin care compositions and nutritional supplements of various types of cream or hydrogel types including collagen, elastin, hyaluronic acid and peptides.
- the present invention also includes a method of slowly releasing Vitamin C according to various conditions of the skin (Aptasensing) through aptamers that react differently depending on the condition of the skin or external stimuli (eg ultraviolet rays or the temperature or acidity of the skin). For example, when the structure of the aptamer is changed by UV irradiation of the skin, the bound antioxidant (e.g., vitamin C) is released or the structure of the aptamer that binds when the amount of ATP changes according to the temperature or acidity of the skin is changed. And a method of releasing Vitamin C as a substitute.
- aptamers that react differently depending on the condition of the skin or external stimuli (eg ultraviolet rays or the temperature or acidity of the skin). For example, when the structure of the aptamer is changed by UV irradiation of the skin, the bound antioxidant (e.g., vitamin C) is released or the structure of the aptamer that binds when the amount of ATP changes according to the temperature or
- the aptamer of the present invention has an antioxidant effect of an antioxidant substance such as vitamin C, and the complex of the aptamer and antioxidant of the present invention may be, for example, contained in Vitamin C (ascorbic acid).
- Vitamin C ascorbic acid
- Aptamers that selectively bind to maintain the reduced state of Vitamin C to maintain its antioxidant function for a long time can be used in functional cosmetics and oral dietary supplements of various formulations.
- RNA or DNA RNA
- Figures 2 to 4 show that the three aptamers of the present invention prevent vitamin C oxidation by hydrogen peroxide solution
- 5 to 10 are graphs of dissociation constants (KD) for AA (ascorbic acid) and DHA (dehydroascorbic acid) of the aptamer of the present invention.
- Example 1 bound to reduced vitamin C Aptamer Military building
- SELEX systematic evolution of ligands by exponential enrichment
- aptamers were selected and subjected to the anti-oxidation experiment of vitamin C. After heating the aptamer dissolved in the annealing buffer to 95 o C and slowly lowering the temperature to room temperature, the secondary structure of the aptamer is mixed. The reaction was carried out for about 30 minutes. After oxidizing conditions by adding hydrogen peroxide solution, oxidation of L-ascorbic acid was measured by adding OPDA (o-phenylenediamine) as a fluorescent dye. DHA, the oxide of L-ascorbic acid, can be quantitatively analyzed by measuring the amount of fluorescence from DHA-OPDA produced by reaction with OPDA. Under the above conditions, the amount of fluorescence of DHA-OPDA was measured every 34 seconds for 25 minutes.
- OPDA o-phenylenediamine
- Example 3 of the present invention Aptamer ascorbic acid (AA) and dehydroascorbic acid ( DHA Steady-state solution dissociation constant (KD)
- Dissociation constants were determined using microscale thermophoresis (MST).
- This example includes the MST data and the calculated KD for the three aptamers in the assay buffer for both targets.
- All reagents containing ascorbic acid and dehydroascorbic acid were purchased from Sigma-Aldrich (St. Louis, MO) and deionized water was treated with Chelex-100 resin for 1 hour to remove accidental metals prior to buffer preparation. After Chelex treatment, the water was sprayed with nitrogen gas for 10 minutes to minimize oxygen and then sealed and stored. This water was used for all aqueous solutions.
- Final buffer is 50 mM sodium acetate, pH 5.5, 1 mM MgCl 2, and 0.05% Tween-20, both AA and DHA were 153 pM (final) at e5 uM in buffer (for aptamers # 10 &# 12) Or at 1: 1 passage dilution at 1.53 nM (final) (Aptamer # 8) at 50 uM.
- the final concentration of each Cy5-conjugated aptamer is 20 nM.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 압타머를 이용한 화장품 및 영양보조제 및 그 제조방법에 관한 것으로, 더욱 상세하게는 압타머에 의한 환원된 비타민 C와 같은 항산화 물질의 장기간 유지 및 산화 방지 특성을 이용하여 이것을 화장품 및 영양보조제에 응용하는 것이다.The present invention relates to cosmetics and nutritional supplements using aptamers and to a method of manufacturing the same, and more particularly, to cosmetics and nutritional supplements using long-term maintenance and antioxidant properties of antioxidants such as reduced vitamin C by aptamers. Is to apply.
노화를 촉진하는 원인들은 여러 가지가 있으나 그 중에서도 활성 산소계(Reactive Oxygen species: ROS)가 상당히 주요한 원인 중 하나인 것으로 받아들여지고 있다. 이러한 활성 산소는 에너지 대사과정, 면역 반응 등에서 필수 불가결하게 생성되며, 외부의 유해 환경에 의해서도 유발되는 피할 수 없는 자극이다. 활성 산소는 반응성이 매우 커서 체내에서 DNA 변성, 과도한 신호전달 유발 및 단백질 변성 등을 초래하여 건강에 해로운 영향을 누적하는 일련의 반응을 일으키게 된다. 그러나, 이러한 유해한 반응들은 생체 내에 존재하는 항산화 물질(uric acid, vit.C, vit.E 등) 또는 항산화 효소(Glutathione peroxidase, superoxide dismutase, catalse 등)에 의해 정교하게 그 항상성을 유지하도록 되어 있다. 그러나, 내인성 노화에 따른 항산화 시스템의 노쇠와 지속적인 유해 자극에 의한 활성 산소의 집적은 이러한 균형을 깨뜨려 건강을 해치게 되며 노화를 촉진시키고, 피부질환, 피부암, 동맥경화 및 혈전과 같은 각종 질병을 유발하기도 한다(Laure Rittie et al., Ageing Research Reviews, 1, 705-720, 2002; Cutler RG, Annals of the New York Academy of Sciences, 1055, 93-135, 2005).There are many causes of aging, but the active oxygen species (ROS) are considered to be one of the major causes. This active oxygen is indispensable in energy metabolism, immune response, etc., and is an unavoidable stimulus caused by external harmful environment. Free radicals are highly reactive and cause DNA denaturation, excessive signaling, and protein denaturation in the body, causing a series of reactions that accumulate harmful effects. However, these harmful reactions are elaborately maintained by antioxidants (uric acid, vit.C, vit.E, etc.) or antioxidant enzymes (Glutathione peroxidase, superoxide dismutase, catalse, etc.) present in vivo. However, the deterioration of antioxidant system due to endogenous aging and the accumulation of free radicals caused by persistent harmful stimuli breaks this balance, impairs health, promotes aging, and causes various diseases such as skin diseases, skin cancer, arteriosclerosis and blood clots. (Laure Rittie et al., Ageing Research Reviews, 1, 705-720, 2002; Cutler RG, Annals of the New York Academy of Sciences, 1055, 93-135, 2005).
따라서, 활성 산소계의 형성을 억제하거나, 형성된 활성 산소계를 제거하는 항산화 물질에 대한 관심이 날로 증가하고 있다. 항산화 물질은 인체 내에 자연적으로 존재하는 것과 외부에서 투여해 주는 것으로 나눌 수 있는데Therefore, there is an increasing interest in antioxidants that inhibit the formation of active oxygen systems or remove the formed active oxygen systems. Antioxidants can be divided into those that exist naturally in the human body and those that are administered externally.
인체 내에 자연적으로 존재하는 항산화 물질로는 과산화 억제효소(superoxide dismutase, SOD), 글루타치온(glutathione), 퍼옥시다아제(peroxidase) 및 카탈라아제(catalase) 등의 효소가 있으며, 외부에서 투여해 주는 것으로는 캠프페롤(kaempferol), 카테킨(catechin) 및 제니스테인(genistein) 등의 피토케미컬(phytochemical); 비타민 E, 비타민 C 및 베타카로틴; 및 셀레니움 등의 미네랄이 있다.Antioxidants that are naturally present in the human body include enzymes such as superoxide dismutase (SOD), glutathione, peroxidase and catalase. phytochemicals such as kaempferol, catechin and genistein; Vitamin E, vitamin C and beta carotene; And minerals such as selenium.
Vitamin C (L-ascorbic acid, ascorbate)는 인간과 여러 동물에게 필수 영향소로, 콜라겐 합성 등에 중요하며, 적어도 8종류의 효소의 보조인자이다. 따라서 Vitamin C가 결핍될 경우 괴혈병 (Scurvy)등의 질환을 유발하게 된다. 동물에서 Vitamin C는 상처의 치유와 모세혈관의 출혈등을 막는 중요한 인자이며 Vitamin A, Vitamin E 등과 더불어 중요한 체내 항산화 물질이다.Vitamin C (L-ascorbic acid, ascorbate) is an essential influencer for humans and animals. It is important for collagen synthesis and is a cofactor for at least eight enzymes. Therefore, vitamin C deficiency will cause diseases such as scurvy (Scurvy). Vitamin C in animals is an important factor in preventing wound healing and capillary bleeding, and is an important antioxidant in the body along with Vitamin A and Vitamin E.
햇빛으로부터 조사되는 자외선A (UVA)와 자외선B (UVB), 공해물질, 스트레스, 흡연, 음주, 지방성 음식물 등으로 인해 발생되는 유리기 (free radical) 와 활성산소 (oxygen free radical) 등에 의해 세포는 공격을 받으며, 이런 물질들로 부터 적절한 보호가 이루어 지지 않을 경우 세포는 노화하거나 사멸하게 된다. 피부의 경우 이런 물질들로 인해 콜라겐이나 엘라스틴 등의 물질의 생산이 줄어들거나 변성되어서 피부가 탄력을 잃고 주름이 생기게 된다. 이를 방지하기 위해 Vitamin A, C, E 등의 항산화 물질들을 포함한 제제를 피부에 도포, 피부내로 흡수시킴으로서 이러한 유해 활성물질에 의한 산화를 막는 것이 피부의 노화를 막는데에 중요한 것으로 공지되어 있다. 하지만 합성 Vitamin C는 공기 중에서 쉽게 산화되어 그 항산화 작용이 사라지게 되는 문제점으로 인해 보관기간이 긴 다양한 제형을 제조하는데 문제가 있다.Cells are attacked by free radicals and oxygen free radicals generated by UVA (UVA) and ultraviolet B (UVB), pollutants, stress, smoking, drinking, fatty foods, etc. In the absence of proper protection from these substances, cells may age or die. In the case of skin, these substances reduce or degenerate the production of collagen and elastin, causing the skin to lose elasticity and wrinkles. In order to prevent this, it is known that it is important to prevent the aging of the skin by preventing the oxidation by the harmful active substances by applying the formulation containing antioxidants such as vitamin A, C, E to the skin, absorbed into the skin. However, due to the problem that the synthetic vitamin C is easily oxidized in the air and its antioxidant action disappears, there is a problem in preparing a variety of formulations with a long shelf life.
[선행 특허 문헌][Previous Patent Document]
대한민국 특허공개번호 10-2015-0079177호Republic of Korea Patent Publication No. 10-2015-0079177
본 발명은 상기의 필요성에 의하여 안출된 것으로서 본 발명의 목적은 항산화 물질의 산화 방지 작용을 하는 물질을 제공하는 것이다.The present invention has been made in view of the above necessity, and an object of the present invention is to provide a substance which acts as an antioxidant for antioxidant substances.
본 발명의 또 다른 목적은 항산화 물질의 산화 방지 작용을 하는 물질의 화장품 및 영양보조제로의 용도를 제공하는 것이다.It is another object of the present invention to provide a cosmetic and nutritional supplement for a substance that acts as an antioxidant for antioxidants.
상기의 목적을 달성하기 위하여 본 발명은 항산화 물질의 산화를 방지하는 압타머를 제공한다.In order to achieve the above object, the present invention provides an aptamer for preventing oxidation of an antioxidant substance.
또 본 발명은 항산화 물질과 상기 본 발명의 압타머를 결합시켜 얻어진 압타머와 항산화물질 복합체를 제공한다.The present invention also provides an aptamer and an antioxidant complex obtained by combining an antioxidant with the aptamer of the present invention.
본 발명의 일 구현예에 있어서, 상기 항산화 물질은 비타민 C, 비타민 A, 레티놀, 비타민E, 아스타잔틴, 레스베라티놀, 폴리페놀, 코엔자임 Q10, 펩티드 및 오일로 구성된 군으로부터 선택된 물질인 것이 바람직하나 이에 한정되지 아니한다.In one embodiment of the invention, the antioxidant is preferably a substance selected from the group consisting of vitamin C, vitamin A, retinol, vitamin E, astaxanthin, resveratinol, polyphenols, coenzyme Q10, peptides and oils. One is not limited thereto.
또 본 발명은 상기 본 발명의 압타머와 항산화물질 복합체를 유효성분으로 포함하는 화장료 조성물을 제공한다.In another aspect, the present invention provides a cosmetic composition comprising the aptamer and antioxidant complex of the present invention as an active ingredient.
본 발명의 일 구현예에 있어서, 상기 화장료 조성물은 콜라젠, 엘라스틴, 히알루론산, 및 펩티드 중 하나 이상을 추가로 포함하는 것이 바람직하나 이에 한정되지 아니한다.In one embodiment of the present invention, the cosmetic composition preferably further comprises one or more of collagen, elastin, hyaluronic acid, and a peptide, but is not limited thereto.
본 발명의 다른 구현예에 있어서, 상기 화장료 조성물은 피부의 자외선 조사에 따라 압타머의 구조가 바뀌면 결합된 항산화 물질(예컨데, 비타민 C)가 방출되게 하거나, 피부의 온도나 산도의 변화에 따라 ATP양이 바뀔 때 이에 결합하는 압타머의 구조가 바뀜으로서 비타민 C를 방출하는 것이 바람직하나 이에 한정되지 아니한다.In another embodiment of the present invention, the cosmetic composition is to release the bound antioxidant (eg, vitamin C) when the structure of the aptamer changes according to the ultraviolet irradiation of the skin, or ATP according to the change in the temperature or acidity of the skin It is preferable to release vitamin C as the structure of the aptamer which binds thereto when the amount is changed, but is not limited thereto.
본 발명의 화장품 조성물은 어떠한 종류의 추출물, 활성물질에 상관없이 화장품에서 사용되는 모든 원료를 사용할 수 있다. 그 예로, 미백에 좋은 녹차추출물, 감초추출물, 닥나무추출물, 상백피추출물, 황금추출물, 푸에리라리아추출물, 홍삼추출물과 노화예방에 좋은 살구추출물, 오일추출물, 오렌지추출물, 레몬추출물, 대나무추출물 구아바추출물 로즈마리추출물 산수유추출물, 영지추출물 은행추출물 서시옥욕산추출물 자음단추출물, 보습에 좋은 모과추출물, 백련초추출물, 파프리카추출물, 알로에추출물, 수세미추출물, 해초추출물, 항산화 효과가 있는 당근추출물, 대두추출물, 자몽씨추출물, 포도씨추출물, 마치현추출물, 주름개선에 도움이 되는 캐비어, 석류, 인삼추출물, 피부재생에 도움이 되는 복숭아추출물, 천궁추출물, 아토피에 좋은 병풀추출물, 캐모마일추출물, 자초근추출물, 고삼추출물, 당귀추출물, 여드름에 좋은 박하추출물, 삼백초추출물, 어성초추출물, 작약추출물, 항염및 항균에 좋은 목초 액, 민들레추출물, 카렌듈라추출물, 황백피추출물, 탱자추출물, 황금추출물, 회향추출물,컴푸리추출물, 모공수출에 도움을 주는 율피추출물, 녹차추출물, 보습기능을 하는 글리세린, 판테놀, 히아루론산 ,세라마이드, 베타글루칸, 미백효과가 있는 알부틴, 비타민C, 화이텐스, 레티놀, 아스타잔틴, 레스베라티놀, 폴리페놀,탄력에 좋은 엘라스틴 ,콜라겐, 코엔자임Q10, 이펙틴, EGF, 항염증 향균제인 프로폴리스, 알란토인, 피토스탄, 인프라산, 항산화제 비타민E(천연토코페롤) ROE(로즈마리오일추출물), 자몽씨추출물 등 다양한 추출물이 적용된다.The cosmetic composition of the present invention can use any raw material used in cosmetics regardless of any kind of extracts, active substances. For example, green tea extract, licorice extract, medicinal extract, lettuce extract, golden extract, pueraria extract, red ginseng extract and apricot extract, oil extract, orange extract, lemon extract, bamboo extract guava extract Rosemary Extract Cornus Extract, Ganoderma Lucidum Extract Ginkgo Extract Seoxiok-Yuksan Extract Consonant Extract, Moisturizing Chinese Quince Extract, White Lotus Extract, Paprika Extract, Aloe Extract, Scrubber Extract, Seaweed Extract, Antioxidant Carrot Extract, Soybean Extract, Grapefruit Extract Grape Seed Extract, Portulaca Extract, Caviar to Improve Wrinkles, Pomegranate, Ginseng Extract, Peach Extract for Skin Regeneration, Cheongung Extract, Centella asiatic Extract, Chamomile Extract, Licorice Extract, Ginseng Extract, Angelica Extract, Acne Good peppermint extract, triticale extract, eosungcho extract , Peony extracts, anti-inflammatory and antibacterial herb extracts, dandelion extracts, calendula extracts, yellow white skin extracts, tanza extracts, golden extracts, fennel extracts, extract extracts, tea extracts, green tea extracts, moisturizing functions Glycerin, Panthenol, Hyaluronic Acid, Ceramide, Beta-Glucan, Whitening Arbutin, Vitamin C, Preference, Retinol, Astaxanthin, Resveratinol, Polyphenols, Elastic Elastin, Collagen, Coenzyme Q10, Epectin, EGF Anti-inflammatory antibacterial propolis, allantoin, phytostane, infra acid, antioxidant vitamin E (natural tocopherol) ROE (rose marioyl extract), grapefruit seed extract is applied.
또 본 발명은 상기 본 발명의 압타머와 항산화 물질 복합체를 유효성분으로 포함하는 영양 보조제 조성물을 제공한다.In another aspect, the present invention provides a nutritional supplement composition comprising the aptamer and antioxidant complex of the present invention as an active ingredient.
본 발명의 영양 보조제에 적합한 비타민의 예는 비타민 A, 비타민 C, 비타민 D, 비타민 E, 비타민 K, 비타민 B 6 , 비타민 B 12 ,티아민, 리보플라빈, 비오틴, 폴산, 니아신, 판토텐산, 이들의 혼합물 등이다. 영양 보조제 조성물에 포함될 적합한 미네랄 영양소의 예는 나트륨, 칼륨, 칼슘, 마그네슘, 인, 황, 염소, 철, 구리, 요오드, 아연, 셀레늄, 망간, 크롬, 몰리브덴, 불소, 코발트, 이들의 화합물에서 선택되는 한가지이상의 원소를 보유하는 것들이다. Examples of suitable vitamins for the nutritional supplements of the present invention include vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, vitamin B 6,
다양한 허브도 영양 보조제로 사용될 수 있다. 일반적으로, 허브는 다양한 의약이나 식이 보조제 특성을 갖는 것들로부터 선택된다. 일반적으로, 허브는 의약용 또는 풍미용으로 사용될 수 있는 방향족 식물이나 식물의 일부분이다.Various herbs can also be used as nutritional supplements. In general, herbs are selected from those having various medicinal or dietary supplement properties. Generally, herbs are aromatic plants or parts of plants that can be used for medicinal or flavoring purposes.
또 본 발명은 항산화 물질에 압타머를 결합시켜 항산화물질의 환원 상태를 유지하고 산화를 방지하는 방법을 제공한다.In another aspect, the present invention provides a method for binding an aptamer to an antioxidant to maintain the reduced state of the antioxidant and prevent oxidation.
이하 본 발명을 설명한다.Hereinafter, the present invention will be described.
본 발명은 Vitamin C와 마찬가지로 Vitamin A(Retinol), Vitamin E, 아스타잔틴, 레스베라티놀, 폴리페놀, 코엔자임 Q10, Peptide, Oil 등 산화에 매우 불안정한 항산화 물질들을 압타머와 결합하여 화장품 및 영양보조제로 제조 사용할 수 있다. 이를 통하여 물질들의 산화(부패)를 방지하게 함으로써 그 물질들이 요구하는 효과를 최대한 유지하도록 한다. 또한, 이를 압타센싱을 통해 목표로 하는 조건에서 방출하도록 함으로써 그 효과를 최대한 증가시킬 수 있다.The present invention, like Vitamin C, vitamin A (Retinol), Vitamin E, Astaxanthin, Resveratinol, Polyphenol, Coenzyme Q10, Peptide, Oil, etc. Can be used to manufacture. This prevents the oxidation (corrosion) of the materials to ensure that they maintain the maximum effect they require. In addition, by releasing it under a target condition through apta-sensing, the effect can be increased as much as possible.
Vitamin C의 환원상태를 유지하는 Maintaining the reduced state of vitamin C 압타머Aptamer
압타머란 single strand DNA나 RNA의 삼차원구조를 이용해 특정 물질을 검출하는 방법으로 항원-항체 반응과 비슷하나 물질의 사이즈가 훨씬 작고, 다양한 방법으로 그 활성을 조절할 수 있으며, 항체에 비해 생산과 보관이 용이한 장점이 있다. 또한 항체와 달리 사이즈가 아주 작은 화학물질 (비타민)등에 결합하는 압타머를 합성할 수도 있으며 화학적 합성에 의해 제조되므로 그 효능을 일정하게 유지하는 데 용이하다. Aptamer is a method of detecting a specific substance by using the three-dimensional structure of single strand DNA or RNA, which is similar to an antigen-antibody reaction, but has a much smaller substance, and can be controlled in various ways. This is an easy advantage. In addition, unlike antibodies, it is possible to synthesize aptamers that bind to very small chemicals (vitamins) and the like.
Vitamin C는 수용성의 6개의 탄소 화합물로, furan 링의 3-,4-, 탄소가 dihydroxy 폼으로 존재하는 환원형과 이부위가 각각 산화된 semidehydroascorbic acid와 dehydroascorbic acid가 있다. Vitamin C is a water-soluble six carbon compound, which includes the 3-, 4- and 3-hydrocarbons of the furan ring and the semidehydroascorbic acid and dehydroascorbic acid, which are oxidized in the reduced form and biparticulate, respectively.
도 1에서 알 수 있는 바와 같이 압타머 (RNA나 DNA)를 구성하는 염기와 Vitamin C의 hydroxyl group의 수소결합 결합을 통해 Vitamin C의 환원 상태를 유지하게 된다.As can be seen in Figure 1 through the hydrogen bonding of the hydroxyl group of the base and vitamin C constituting the aptamer (RNA or DNA) to maintain the reduced state of Vitamin C.
압타머와With aptamers 결합하고 있는 Vitamin C를 사용한 다양한 제형 Various formulations using vitamin C in combination
압타머와 결합하여 환원상태를 유지하고 있는 Vitamin C를 콜라젠, 엘라스틴, 히알루론산, 펩티드 등을 포함하는 크림 타입 혹은 하이드로젤 타입의 다양한 제형의 피부미용 조성물과 영양보조제에 사용할 수 있다. Vitamin C, which is combined with aptamers and maintains a reduced state, may be used in skin care compositions and nutritional supplements of various types of cream or hydrogel types including collagen, elastin, hyaluronic acid and peptides.
피부 컨디션이나 외부자극에 따른 Vitamin C의 방출조절Control of Vitamin C Release According to Skin Condition or External Stimulation
본 발명은 또한 피부의 상태나 외부자극에 따라 (예컨데 자외선이나 피부의 온도나 산도) 다르게 반응하는 압타머를 통해 (Aptasensing) 피부의 다양한 컨디션에 따라 Vitamin C를 서서히 방출하게 하는 방법을 포함한다. 예컨데 피부의 자외선 조사에 따라 압타머의 구조가 바뀌면 결합된 항산화 물질(예컨데, 비타민 C)가 방출되게 하거나, 피부의 온도나 산도의 변화에 따라 ATP양이 바뀔 때 이에 결합하는 압타머의 구조가 바뀜으로서 Vitamin C를 방출하게 하는 방법 등을 포함한다. The present invention also includes a method of slowly releasing Vitamin C according to various conditions of the skin (Aptasensing) through aptamers that react differently depending on the condition of the skin or external stimuli (eg ultraviolet rays or the temperature or acidity of the skin). For example, when the structure of the aptamer is changed by UV irradiation of the skin, the bound antioxidant (e.g., vitamin C) is released or the structure of the aptamer that binds when the amount of ATP changes according to the temperature or acidity of the skin is changed. And a method of releasing Vitamin C as a substitute.
본 발명을 통하여 알 수 있는 바와 같이, 본 발명의 압타머는 비타민C와 같은 항산화 물질의 산화방지 효과를 가지며, 본 발명의 압타머와 항산화물질의 복합체는 예를 들어, Vitamin C (ascorbic acid)에 선택적으로 결합하는 압타머를 이용해 Vitamin C의 환원 상태를 유지해서 그 항산화 기능을 장기간 유지하게 하여 다양한 제형의 기능성 화장품과 경구용 영양보조제 (dietary supplements) 등에 이용할 수 있다.As can be seen through the present invention, the aptamer of the present invention has an antioxidant effect of an antioxidant substance such as vitamin C, and the complex of the aptamer and antioxidant of the present invention may be, for example, contained in Vitamin C (ascorbic acid). Aptamers that selectively bind to maintain the reduced state of Vitamin C to maintain its antioxidant function for a long time can be used in functional cosmetics and oral dietary supplements of various formulations.
도 1은 압타머 (RNA나 DNA)를 구성하는 염기와 Vitamin C의 hydroxyl group의 수소결합 결합을 통해 Vitamin C의 환원 상태를 유지하는 그림,1 is a diagram of maintaining the reduced state of vitamin C through hydrogen bonding of the hydroxyl group of the base and vitamin C constituting the aptamer (RNA or DNA),
도 2 내지 4는 본 발명의 세 개의 압타머가 과산화수소수에 의한 비타민C 산화를 방지하는 것을 보여주는 그림,Figures 2 to 4 show that the three aptamers of the present invention prevent vitamin C oxidation by hydrogen peroxide solution,
도 5 내지 10은 본 발명의 압타머의 AA(ascorbic acid) 및 DHA(dehydroascorbic acid)에 대한 해리 상수(KD) 그래프.5 to 10 are graphs of dissociation constants (KD) for AA (ascorbic acid) and DHA (dehydroascorbic acid) of the aptamer of the present invention.
이하 본 발명을 비한정적인 실시예를 통하여 상세하게 설명한다. 단 하기 실시예는 본 발명을 예시하기 위한 의도로 기재된 것으로서 본 발명의 범위는 하기 실시예에 의하여 제한되는 것으로 해석되지 아니한다.Hereinafter, the present invention will be described in detail through non-limiting examples. However, the following examples are intended to illustrate the invention and the scope of the present invention is not to be construed as limited by the following examples.
실시예Example 1: 환원상태의 Vitamin C에 결합하는 1: bound to reduced vitamin C 압타머Aptamer 군 구축 Military building
SELEX (systematic evolution of ligands by exponential enrichment) 과정을 통해 1013 개로 구성된 DNA 압타머 라이브러리로 부터 환원상태의 ascorbic acid에 대해 선택적으로 결합하는 압타머를 찾는 실험을 다음의 조건에서 진행하였다. Ascorbic acid의 환원 상태를 유지한 상태에서 SELEX를 진행하기 위해, ~pH 5.5 정도로 유지하며 glutathione 을 넣어주었다.SELEX (systematic evolution of ligands by exponential enrichment) was performed to find aptamers that selectively bind to reduced ascorbic acid from 10 13 DNA aptamer libraries under the following conditions. In order to proceed with the SELEX while maintaining the reduced state of ascorbic acid, glutathione was added while maintaining the pH around 5.5.
이 조건 하에서 비타민C의 99% 이상이 산화된 dehydro ascorbic acid (DHA)가 아니 환원된 L-ascorbic acid 상태로 유지가 되었다. 위의 반응 조건에서 SELEX를 진행하여 선택된 압타머 전체를 Next Generation Sequencing을 진행한 후 분석한 결과, 3000개 이상의 2차구조군으로 이뤄진 압타머를 얻을 수 있었다.Under this condition, more than 99% of vitamin C remained in reduced L-ascorbic acid state, not oxidized dehydro ascorbic acid (DHA). Under the above reaction conditions, SELEX was carried out and the entire selected aptamer was subjected to Next Generation Sequencing and analyzed. As a result, an aptamer composed of more than 3000 secondary structures was obtained.
실시예Example 2: 2: 압타머를Aptamer 통한 비타민 C 산화방지 정량분석 Quantitative Analysis of Antioxidant Vitamin C
이차 구조의 종류에 따라 20개의 개별 압타머를 선택하여 비타민C의 산화 방지 실험을 진행하였다. Annealing buffer에 녹인 압타머를 95 oC 로 가열한 후 서서히 온도를 상온으로 내리면서 압타머의 이차 구조를 만든 후, 환원된 L-ascorbic acid와 혼합하여 압타머가 L-ascorbic acid와 결합할 수 있도록 약 30분간 반응시켰다. 이 후 과산화수소수를 첨가하여 산화조건을 만들어 준 후 L-ascorbic acid의 산화를 형광염료인 OPDA (o-phenylenediamine) 를 첨가하여 측정하였다. L-ascorbic acid의 산화물인 DHA가 OPDA와 반응하여 생성된 DHA-OPDA로 부터의 형광량을 측정하여 DHA의 생성 정도를 정량 분석할 수 있다. 위의 조건에서 DHA-OPDA의 형광량을 매 34초마다 25분 동안 측정하였다.According to the type of secondary structure, 20 individual aptamers were selected and subjected to the anti-oxidation experiment of vitamin C. After heating the aptamer dissolved in the annealing buffer to 95 o C and slowly lowering the temperature to room temperature, the secondary structure of the aptamer is mixed. The reaction was carried out for about 30 minutes. After oxidizing conditions by adding hydrogen peroxide solution, oxidation of L-ascorbic acid was measured by adding OPDA (o-phenylenediamine) as a fluorescent dye. DHA, the oxide of L-ascorbic acid, can be quantitatively analyzed by measuring the amount of fluorescence from DHA-OPDA produced by reaction with OPDA. Under the above conditions, the amount of fluorescence of DHA-OPDA was measured every 34 seconds for 25 minutes.
이 중 세 개의 모든 압타머는 과산화수소수에 의한 비타민C 산화를 방지하였다. 12번 압타머는 약 40 %의 산화를 방지하였고, 8번은 약 20 %, 10번은 약 40 %의 산화를 방지 효과를 보였다. 이러한 실험 및 다른 경험에 근거하여, 세 개의 압타머가 비타민C에 직접 반응하여, 비타민C의 산화를 방지한다는 결론을 내릴 수 있다 (도 2 내지 4 참조).All three aptamers prevented vitamin C oxidation by hydrogen peroxide.
실시예Example 3: 본 발명의 3: of the present invention 압타머의Aptamer ascorbic acid (AA) 및 ascorbic acid (AA) and dehydroascorbicdehydroascorbic acid ( acid ( DHADHA )에 대한 steady-state 용액 해리 상수(KD) 결정Steady-state solution dissociation constant (KD)
해리 상수는 MST(microscale thermophoresis)를 사용하여 결정하였다. Dissociation constants were determined using microscale thermophoresis (MST).
본 실시예는 양 타겟에 대한 어세이 버퍼에서 세 압타머에 대한 MST 데이터 및 계산된 KD를 포함한다. ascorbic acid 및 dehydroascorbic acid를 포함하는 모든 시약은 Sigma-Aldrich (St. Louis, MO)에서 구입하였고, 버퍼 제조 전에, 탈이온수를 Chelex-100 레진으로 1시간 동안 처리하여 우발적인 금속을 제거하였다. Chelex 처리 후, 그 물을 산소를 최소화하기 위하여 질소 가스로 10분간 살포한 후 밀봉하여 보관하였다. 이 물을 모든 수용액에 사용하였다. 최종 버퍼는 50 mM sodium acetate, pH 5.5, 1 mM MgCl2, 및 0.05% Tween-20이고, 양 AA 및 DHA 모두는 버퍼에서 e5 uM 에서 153 pM (최종) (압타머 #10 & #12에 대해) 또는 50 uM 에서 1.53 nM (최종) (압타머 #8)에서 1:1 계대 희석에서 분석하였다. 각 Cy5-conjugated 압타머의 최종 농도는 20 nM이다. This example includes the MST data and the calculated KD for the three aptamers in the assay buffer for both targets. All reagents containing ascorbic acid and dehydroascorbic acid were purchased from Sigma-Aldrich (St. Louis, MO) and deionized water was treated with Chelex-100 resin for 1 hour to remove accidental metals prior to buffer preparation. After Chelex treatment, the water was sprayed with nitrogen gas for 10 minutes to minimize oxygen and then sealed and stored. This water was used for all aqueous solutions. Final buffer is 50 mM sodium acetate, pH 5.5, 1 mM MgCl 2, and 0.05% Tween-20, both AA and DHA were 153 pM (final) at e5 uM in buffer (for
각 기술적인 두번 희석물을 NanoTemper Technologies GmbH (Munich, Germany) 사의 Monolith NT.115 MST 장치에서 2회 측정하였다. Each technical double dilution was measured twice on a Monolith NT.115 MST instrument from NanoTemper Technologies GmbH (Munich, Germany).
그 결과는 도 5 내지 10에 나타내었다. 각 데이터 포인트는 평균과 맞춤 곡선(fitted curve; 검은 선)과 함께 도에서 나타낸다. 각 그래프의 수직 파선은 KD를 나타낸다. The results are shown in Figures 5 to 10. Each data point is shown in the figure with an average and a fitted curve (black line). Vertical dashed lines in each graph represent KD.
상기 결과를 통하여 하기와 같은 결론을 추론하였다.The following conclusions were inferred from the above results.
1)압타머 #10 & 12는 AA vs DHA에 대하여 더 우수한 선택성을 가지는 반면, #8은 DHA에 대해서 AA보다 약간 더 우수한 선택성을 가진다. 1) Aptamers # 10 & 12 have better selectivity for AA vs DHA, while # 8 has slightly better selectivity than AA for DHA.
2) 압타머 #10 세 압타머의 AA vs DHA에 대한 가장 우수한 선택성을 가진다. 2)
3) 압타머 #12는 산화로부터 AA의 보호에는 최고이었으나 AA vs DHA의 최소 선택성을 가졌다. 3)
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2017/004823 WO2017196077A1 (en) | 2016-05-12 | 2017-05-10 | Cosmetic and nutritional supplement using aptamer, and method for producing same |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2016-0058022 | 2016-05-12 | ||
| KR20160058022 | 2016-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2017195951A1 true WO2017195951A1 (en) | 2017-11-16 |
Family
ID=60266544
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2016/011741 Ceased WO2017195951A1 (en) | 2016-05-12 | 2016-10-19 | Cosmetic and nutritional supplement using aptamer, and method for producing same |
| PCT/KR2017/004823 Ceased WO2017196077A1 (en) | 2016-05-12 | 2017-05-10 | Cosmetic and nutritional supplement using aptamer, and method for producing same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2017/004823 Ceased WO2017196077A1 (en) | 2016-05-12 | 2017-05-10 | Cosmetic and nutritional supplement using aptamer, and method for producing same |
Country Status (1)
| Country | Link |
|---|---|
| WO (2) | WO2017195951A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020096296A1 (en) * | 2018-11-06 | 2020-05-14 | 주식회사 넥스모스 | Method for preventing oxidation of polyphenol by means of aptamer, material thereof, and use thereof |
| CN113164442A (en) * | 2018-10-25 | 2021-07-23 | (株)纳斯摩仕 | Composition for improving and treating depilation, hair damage and skin disease in animals comprising Aptamin-C as active ingredient |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108543079B (en) * | 2018-05-22 | 2019-12-24 | 广东药科大学 | A kind of astaxanthin-collagen coupling substance and its preparation method and application |
| WO2020096240A1 (en) * | 2018-11-06 | 2020-05-14 | 주식회사 넥스모스 | Dna aptamer specifically binding to glutathione and use thereof |
| WO2020222506A1 (en) * | 2019-05-02 | 2020-11-05 | 주식회사 넥스모스 | Oral composition comprising aptamer as active ingredient |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235721B1 (en) * | 1999-02-17 | 2001-05-22 | Natreon Inc. | Stabilization of vitamin C |
| US20070112064A1 (en) * | 2003-07-24 | 2007-05-17 | Lyles Mark B | Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof |
| WO2009031788A1 (en) * | 2007-09-04 | 2009-03-12 | Cotde, Ltd. | Cosmetic composition comprising vitamin c |
| KR20120043167A (en) * | 2009-04-09 | 2012-05-03 | 시므라이즈 아게 | Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
-
2016
- 2016-10-19 WO PCT/KR2016/011741 patent/WO2017195951A1/en not_active Ceased
-
2017
- 2017-05-10 WO PCT/KR2017/004823 patent/WO2017196077A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235721B1 (en) * | 1999-02-17 | 2001-05-22 | Natreon Inc. | Stabilization of vitamin C |
| US20070112064A1 (en) * | 2003-07-24 | 2007-05-17 | Lyles Mark B | Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof |
| WO2009031788A1 (en) * | 2007-09-04 | 2009-03-12 | Cotde, Ltd. | Cosmetic composition comprising vitamin c |
| KR20120043167A (en) * | 2009-04-09 | 2012-05-03 | 시므라이즈 아게 | Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
Non-Patent Citations (2)
| Title |
|---|
| HE, XIAOXIAO ET AL.: "ATP-Responsive Controlled Release System Using Aptamer -Functionalized Mesoporous Silica Nanoparticles", LANGMUIR, vol. 28, no. 35, 23 August 2012 (2012-08-23), pages 12909 - 12915, XP055106436 * |
| KRYLOVA, SVETLANA M. ET AL.: "Mechanistic Studies on the Application of DNA Aptamers as Inhibitors of 2-oxoglutarate-dependent Oxygenases", JOURNAL OF MEDICINAL CHEMISTRY, vol. 55, no. 7, 3 March 2012 (2012-03-03), pages 3546 - 3552, XP055414197 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113164442A (en) * | 2018-10-25 | 2021-07-23 | (株)纳斯摩仕 | Composition for improving and treating depilation, hair damage and skin disease in animals comprising Aptamin-C as active ingredient |
| WO2020096296A1 (en) * | 2018-11-06 | 2020-05-14 | 주식회사 넥스모스 | Method for preventing oxidation of polyphenol by means of aptamer, material thereof, and use thereof |
| CN113439122A (en) * | 2018-11-06 | 2021-09-24 | (株)纳斯摩仕 | Method for preventing oxidation of polyphenols using aptamers, substances thereof and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017196077A1 (en) | 2017-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017150891A1 (en) | Antioxidation method for antioxidant material, and material and use for same | |
| Singh et al. | Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health | |
| WO2017196077A1 (en) | Cosmetic and nutritional supplement using aptamer, and method for producing same | |
| Kinney et al. | Overall skin health potential of the biofield energy healing based herbomineral formulation using various skin parameters | |
| Pallab et al. | Estimation of total flavonoids content (TPC) and antioxidant activities of methanolic whole plant extract of Biophytum sensitivum Linn | |
| ES2810848T3 (en) | Microcapsules containing active agent | |
| KR20220027092A (en) | Cosmetic composition | |
| Kauser et al. | In vitro antioxidant and cytotoxic potential of methanolic extracts of selected indigenous medicinal plants | |
| CA3038495C (en) | Method for preventing oxidation of antioxidant material using aptamer, material, and use thereof | |
| JP2004538381A (en) | Cosmetic and anti-aging stockings or pantyhose impregnated with slowly released natural substances and methods of making the same | |
| WO2018092968A1 (en) | Vitamin and antioxidant beverage and food using aptamer, and method for producing same | |
| Ermini et al. | Copper nano-architecture topical cream for the accelerated recovery of burnt skin | |
| Padule et al. | The advancement of herbal-based nanomedicine for hair | |
| CA2896348A1 (en) | Skin care compositions comprising folic acid and gallated catechin | |
| JP2016190823A (en) | Nerve growth factor inhibitor | |
| KR20130052288A (en) | Cosmetic composition comprising the hot spring water extract of nelumbo nucifera gaertner as active ingredient | |
| Türkoğlu et al. | Antioxidants and Antiaging | |
| Karthishwaran et al. | Assessment of the antioxidant potential of Pergularia daemia (Forsk.) extract in vitro and in vivo experiments on hamster buccal pouch carcinogenesis | |
| US20050031710A1 (en) | Method of personal care and cosmetic product preparation and composition using human blood type | |
| Hirobe | Iron and skin health: iron stimulates skin function | |
| Yepes-Molina et al. | Nanoencapsulation of Pomegranate Extract to Increase Stability and Potential Dermatological Protection. Pharmaceutics 2021, 13, 271 | |
| Koster et al. | Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine | |
| Banik et al. | Biosynthesized colloidal metallic nanoparticles-based nanocosmetic formulations | |
| Meagher et al. | An in vitro study of biofield energy healing based herbomineral formulation for skin protection | |
| Ibišević et al. | Tyrosinase inhibition, antioxidative and antimicrobial activity of active substances and creams used in the treatment of hyperpigmentation (kojic acid, niacinamide and grapevine extract) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16901784 Country of ref document: EP Kind code of ref document: A1 |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/02/2019) |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22.02.2019) |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16901784 Country of ref document: EP Kind code of ref document: A1 |